Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
4.480
-0.020 (-0.44%)
At close: Jun 4, 2025

EGX:RMDA Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
3,1782,7691,9221,4841,246960.17
Upgrade
Revenue Growth (YoY)
59.98%44.03%29.54%19.06%29.81%7.41%
Upgrade
Cost of Revenue
1,6921,4871,018765.28669.61514.34
Upgrade
Gross Profit
1,4861,281904.06718.67576.82445.83
Upgrade
Selling, General & Admin
607.14558.11444.06360.96303.18258.18
Upgrade
Other Operating Expenses
-27.93-27.3-7.34-6.04-0.76-1.16
Upgrade
Operating Expenses
608.22558.54458.3376.41302.53258.82
Upgrade
Operating Income
878.07722.93445.76342.26274.29187.01
Upgrade
Interest Expense
-376.94-307.21-191.2-89.07-91.03-96.64
Upgrade
Interest & Investment Income
60.5765.8562.956.7359.9764.16
Upgrade
Currency Exchange Gain (Loss)
7.1256.2418.6825.65-0.6-1.7
Upgrade
Other Non Operating Income (Expenses)
-13.67-11.7-8.84-6.99-8.31-7.58
Upgrade
EBT Excluding Unusual Items
555.14526.11327.31328.58234.33145.25
Upgrade
Gain (Loss) on Sale of Assets
0.10.010.14-0.13-0.72-0.14
Upgrade
Pretax Income
555.24526.12327.45328.45233.61145.11
Upgrade
Income Tax Expense
127.65124.3174.2475.5753.5233.59
Upgrade
Earnings From Continuing Operations
427.6401.81253.21252.89180.09111.51
Upgrade
Minority Interest in Earnings
-15-14.44-8.35-7.2110.67
Upgrade
Net Income
412.6387.37244.86245.68181.09112.18
Upgrade
Preferred Dividends & Other Adjustments
23.5323.5321.3616.7614.714.7
Upgrade
Net Income to Common
389.08363.84223.5228.91166.3997.48
Upgrade
Net Income Growth
75.31%58.20%-0.33%35.67%61.43%36.15%
Upgrade
Shares Outstanding (Basic)
1,5001,4971,4911,4751,5231,523
Upgrade
Shares Outstanding (Diluted)
1,5091,5051,5011,4831,5231,523
Upgrade
Shares Change (YoY)
0.26%0.23%1.27%-2.62%--
Upgrade
EPS (Basic)
0.260.240.150.160.110.06
Upgrade
EPS (Diluted)
0.260.240.150.150.110.06
Upgrade
EPS Growth
81.35%62.39%-3.56%41.28%70.69%18.31%
Upgrade
Free Cash Flow
-191.3-371.85-135.54-5.03188.68-249.31
Upgrade
Free Cash Flow Per Share
-0.13-0.25-0.09-0.000.12-0.16
Upgrade
Dividend Per Share
--0.067---
Upgrade
Gross Margin
46.77%46.28%47.03%48.43%46.28%46.43%
Upgrade
Operating Margin
27.63%26.11%23.19%23.06%22.01%19.48%
Upgrade
Profit Margin
12.24%13.14%11.63%15.43%13.35%10.15%
Upgrade
Free Cash Flow Margin
-6.02%-13.43%-7.05%-0.34%15.14%-25.96%
Upgrade
EBITDA
959.95802.33514.61403.67316.61239.55
Upgrade
EBITDA Margin
30.20%28.98%26.77%27.20%25.40%24.95%
Upgrade
D&A For EBITDA
81.8879.468.8561.4142.3152.54
Upgrade
EBIT
878.07722.93445.76342.26274.29187.01
Upgrade
EBIT Margin
27.63%26.11%23.19%23.06%22.01%19.48%
Upgrade
Effective Tax Rate
22.99%23.63%22.67%23.01%22.91%23.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.